View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Tislelizumab 400, Non-Small Cell Lung Cancer, adjuvant, Cycle 4-11
Protocol-ID: 2921 V1.0 (Mini), TISL400, NSCLC, adj., C4-11Indication(s)
- Lung Carcinoma, Non-Small Cell; ICD-10 C34.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 28.05.2025